MO

O'Brien, Margaret

MRN-001019

57 y/o · Dr. Lisa Wong

Diagnosis

Invasive Lobular Carcinoma

Stage

Stage IA

ER+/PR+/HER2-, E-cadherin negative, Ki-67 12%

NCCN: Invasive Lobular Carcinoma, HR+

Active

19 open tasks · 17 verified

Last review: Apr 15, 2026 · Breast Oncology Tumor Board

Referred

Apr 10

Evaluation

Apr 17

6d

Board Review

Pre-Treatment

Treatment

Surveillance

In Evaluation for 6 days

Loading care timeline...

Board History & Recommendations

Neoadjuvant vs. upfront surgical approach for cT2N1 triple-negative disease.

Presenting: Dr. Lisa Wong

25 days between presentations

21 days between presentations

29 days between presentations

21 days between presentations

Active Tasks

Coordination Notes

Clinical Profile

Diagnosis

Invasive Lobular Carcinoma

Stage

Stage IA

Referring

Dr. Lisa Wong

Biomarkers

ER+/PR+/HER2-E-cadherin negativeKi-67 12%

Clinical Data

Import clinical data from Epic

Pull pathology, imaging, labs, and clinical notes via FHIR